Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AddChemo: Adjuvant Chemotherapy in cfHPV-DNA Positive Cervical Cancer
NCT05764044Phase 3Recruiting
- Sponsor
- HCor
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, gemcitabine in Cervical Cancer (CC), sponsored by HCor. Started Mar 2024; status: recruiting.
02
Drugs
cisplatingemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT05764044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764044.